These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 1465454)
1. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454 [TBL] [Abstract][Full Text] [Related]
2. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455 [TBL] [Abstract][Full Text] [Related]
3. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990 [TBL] [Abstract][Full Text] [Related]
5. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin. Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced in vivo sickling of transgenic mouse red cells. Rubin EM; Witkowska HE; Spangler E; Curtin P; Lubin BH; Mohandas N; Clift SM J Clin Invest; 1991 Feb; 87(2):639-47. PubMed ID: 1991848 [TBL] [Abstract][Full Text] [Related]
7. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease. He Z; Russell JE Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human hemoglobins designed for gene therapy of sickle cell disease. McCune SL; Reilly MP; Chomo MJ; Asakura T; Townes TM Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9852-6. PubMed ID: 7937904 [TBL] [Abstract][Full Text] [Related]
9. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin. Reilly MP; Chomo MJ; Obata K; Asakura T Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846 [TBL] [Abstract][Full Text] [Related]
10. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia. Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593 [TBL] [Abstract][Full Text] [Related]
11. Effect of human beta (s)-globin chains on cellular properties of red cells from beta-thalassemic mice. Rubin EM; Kan YW; Mohandas N J Clin Invest; 1988 Sep; 82(3):1129-33. PubMed ID: 3417869 [TBL] [Abstract][Full Text] [Related]
12. High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. Hanscombe O; Vidal M; Kaeda J; Luzzatto L; Greaves DR; Grosveld F Genes Dev; 1989 Oct; 3(10):1572-81. PubMed ID: 2612906 [TBL] [Abstract][Full Text] [Related]
13. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Ye L; Chang JC; Lu R; Kan YW Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438 [TBL] [Abstract][Full Text] [Related]
14. Functional effects of replacing human alpha- and beta-globins with their embryonic globin homologues in defined haemoglobin heterotetramers. He Z; Lian L; Asakura T; Russell JE Br J Haematol; 2000 Jun; 109(4):882-90. PubMed ID: 10929046 [TBL] [Abstract][Full Text] [Related]
15. A transgenic mouse model of hemoglobin S Antilles disease. Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele. Noguchi CT; Gladwin M; Diwan B; Merciris P; Smith R; Yu X; Buzard G; Fitzhugh A; Keefer LK; Schechter AN; Mohandas N Blood Cells Mol Dis; 2001; 27(6):971-7. PubMed ID: 11831863 [TBL] [Abstract][Full Text] [Related]
17. Complementation of alpha-thalassaemia in alpha-globin knockout mice with a 191 kb transgene containing the human alpha-globin locus. Al-Hasani K; Vadolas J; Voullaire L; Williamson R; Ioannou PA Transgenic Res; 2004 Jun; 13(3):235-43. PubMed ID: 15359601 [TBL] [Abstract][Full Text] [Related]
18. Effect of zeta-globin substitution on the O2-transport properties of Hb S in vitro and in vivo. He Z; Russell JE Biochem Biophys Res Commun; 2004 Dec; 325(4):1376-82. PubMed ID: 15555579 [TBL] [Abstract][Full Text] [Related]
19. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459 [TBL] [Abstract][Full Text] [Related]
20. Genetic variation in mouse beta globin cysteine content modifies glutathione metabolism: implications for the use of mouse models. Hempe JM; Ory-Ascani J; Hsia D Exp Biol Med (Maywood); 2007 Mar; 232(3):437-44. PubMed ID: 17327478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]